Patents by Inventor Mahesh C. Sharma

Mahesh C. Sharma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for inhibiting angiogenesis
    Patent number: 7625868
    Abstract: Methods for inhibiting angiogenesis in endothelial cells and selectively inducing apoptosis in endothelial cells via compounds which binds annexin II are provided. These compounds and methods for using these compounds are useful in the treatment of diseases or disorders characterized by unwanted angiogenesis. Also provided are pharmaceutical compositions containing a compound which binds annexin II and a pharmaceutically acceptable vehicle and methods for identifying such compounds.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: December 1, 2009
    Assignee: Philadelphia, Health and Education Corporation
    Inventors: Mahesh C. Sharma, George P. Tuszynski
  • Methods and compositions for inhibiting angiogenesis
    Patent number: 7160858
    Abstract: Methods for inhibiting angiogenesis in endothelial cells and selectively inducing apoptosis in endothelial cells via compounds which binds annexin II are provided. These compounds and methods for using these compounds are useful in the treatment of diseases or disorders characterized by unwanted angiogenesis. Also provided are pharmaceutical compositions containing a compound which binds annexin II and a pharmaceutically acceptable vehicle and methods for identifying such compounds.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: January 9, 2007
    Assignee: Philadelphia, Health and Education Corporation
    Inventors: Mahesh C. Sharma, George P. Tuszynski
  • Methods and compositions for inhibiting angiogenesis
    Publication number: 20040109864
    Abstract: Methods for inhibiting angiogenesis in endothelial cells and selectively inducing apoptosis in endothelial cells via compounds which binds annexin II are provided. These compounds and methods for using these compounds are useful in the treatment of diseases or disorders characterized by unwanted angiogenesis. Also provided are pharmaceutical compositions containing a compound which binds annexin II and a pharmaceutically acceptable vehicle and methods for identifying such compounds.
    Type: Application
    Filed: May 9, 2003
    Publication date: June 10, 2004
    Inventors: Mahesh C. Sharma, George P. Tuszynski